The Crosetto Foundation for the Reduction of Cancer Deaths has issued an urgent appeal to Members of the European Parliament to address what it describes as a misallocation of public funding at CERN. The foundation advocates for the immediate adoption of Dario Crosetto's 3D-Flow technology, a breakthrough invention with demonstrated potential to transform both particle physics research and medical diagnostics. This call comes amid concerns about continued investment in less effective systems despite clear evidence of superior alternatives.
Dario Crosetto's 3D-Flow architecture, which received recognition from a scientific panel at FERMILAB in 1993, offers unprecedented flexibility, performance, and cost-effectiveness in processing ultra-high-data streams. The technology has proven its feasibility through a $1 million grant demonstration, yet CERN persists in funding Field Programmable Gate Array-based architectures that have repeatedly failed to meet performance requirements. This persistence has resulted in significant financial waste according to foundation analysis.
The implications extend beyond particle physics research efficiency. The 3D-Flow technology forms the foundation for 3D-Complete Body Screening, an advanced PET/CT technology designed for early disease detection. Crosetto's inventions could potentially save lives by enabling earlier cancer detection, reducing healthcare costs, and improving overall societal well-being. The foundation argues that the technology's dual application in both scientific research and medical diagnostics represents an unprecedented opportunity for European innovation.
A public scientific comparison reveals stark differences between current systems and the proposed technology. CERN's existing FPGA-based Level-1 Trigger system consumes 650 kW of power while performing only 66 operations, whereas Crosetto's 3D-Flow system requires just 6 kW for over 8,000 operations. This represents more than a hundredfold improvement in energy efficiency and computational capability. The foundation has formally requested a public scientific meeting to demonstrate these comparative advantages to stakeholders and decision-makers.
The Crosetto Foundation's appeal emphasizes the need for greater transparency, accountability, and responsible use of taxpayer money in scientific funding decisions. It highlights the critical importance of accelerating adoption of life-saving technologies while ensuring fair and open scientific evaluations. The foundation specifically urges Members of the European Parliament to submit a Parliamentary Question addressing these funding allocation concerns and redirecting resources toward genuinely advanced scientific solutions. This intervention could potentially save billions in public funds while advancing both particle physics research and medical technology simultaneously.
